Features
Surgical Roundtable Case 1: Managing Giant Retinal Tears
Mrinali Gupta, MD, FASRS, demonstrates surgical repair of a traumatic giant retinal tear (GRT) detachment in a 50-year-old phakic patient.
By Christina Y. Weng, MD, MBA, Mrinali Gupta, MD, FASRS, Nimesh A. Patel, MD, et al.
Surgical Roundtable Case 2: Managing a Dislocated Scleral-Fixated IOL
Nimesh A. Patel, MD, demonstrates management of a dislocated Akreos AO60 intraocular lens (IOL; Bausch + Lomb) that had been previously fixated with Prolene sutures.
By Christina Y. Weng, MD, MBA, Nimesh A. Patel, MD, Frank Brodie, MD, MBA, et al.
Surgical Roundtable Case 3: Fixing a Tilted Secondary IOL
Christina Weng, MD, MBA, presents a case of secondary IOL tilt correction, highlighting a novel 5-point scaffold technique for lens stabilization.
By Christina Y. Weng, MD, MBA, Mrinali Gupta, MD, FASRS, Nimesh A. Patel, MD, et al.
Surgical Roundtable Case 4: Implanting a Subretinal Photovoltaic Prosthesis
Frank Brodie, MD, MBA, presents the surgical technique for subretinal placement of the PRIMA implant, an investigational therapy for advanced geographic atrophy.
By Christina Y. Weng, MD, MBA, Frank Brodie, MD, MBA, Mrinali Gupta, MD, FASRS, et al.
What to Expect at ASRS 2026
ASRS program chair Nina Berrocal, MD, FASRS, previews the surgical sessions, new features, and networking opportunities planned for Montreal.
By Audina M. Berrocal, MD
Emerging Trends in Intraocular Tamponade
Current advances, clinical trade-offs, and persistent unmet needs in retinal detachment repair.
By Chi Phan, BS, Ali Elobous, MD, Alice Yang Zhang, MD
Vitreoretinal Surgery at High Altitude
Elevation affects vitrectomy fluidics, intraocular gas behavior, tamponade selection, and postoperative travel planning.
By Christine I. Clavell, MD, James P. Dossett, MD
Building a Retina Surgery Program in Sierra Leone
A mission team reflects on surgical innovation, logistical challenges, and the long-term goal of building sustainable vitreoretinal care in West Africa.
By Sean J. Jin, MD, Tedi Begaj, MD, Lloyd Harrison-Williams, MBBS, et al.
Managing Massive Subretinal Hemorrhage Without Surgery
Two patients with massive subretinal hemorrhage demonstrated sustained long-term stability following intravitreal anti-VEGF monotherapy.
By Michael Y. Zhao, MD, Harry W. Flynn Jr., MD
The Benefits of Intravitreal Steroids During Vitrectomy
Triamcinolone acetonide enhances vitreous visualization, facilitates surgical maneuvers, and provides postoperative anti-inflammatory effects.
By John W. Kitchens, MD
Web Exclusives
Rethinking Retinal Fluid in Neovascular AMD
New evidence suggests that maintaining anatomic stability, rather than eliminating all retinal fluid, may improve long-term outcomes.
By Durga S. Borkar, MD, MMCi
An Unusual Case of Pediatric CRAO
Multiple acquired and inherited risk factors may have contributed to central retinal artery occlusion in an otherwise healthy adolescent.
By Mohan Bhadriraju, BA, Rishabh Gupta, MD, Veena Raiji, MD
Managing the Revenue Cycle Through Staff Turnover
A resilient revenue cycle depends on systems that withstand personnel changes, not individual expertise.
By Elizabeth Cifers, MBA, MSW, CHC, CPC
Connecting Structure and Function in GA
Post hoc GATHER2 analyses suggest ellipsoid zone integrity and low-luminance deficit may provide complementary measures of disease progression and treatment response.
By Jim Gallagher, senior managing editor
Departments
Emphasis on Vitreoretinal Surgery
Upfront
The July/August issue has a focus on vitreoretinal surgery.
By Diana V. Do, MD
Approaching Uveitic Retinal Detachments
Uveitis Corner
Careful control of inflammation, thoughtful surgical planning, and vigilant postoperative management can help optimize outcomes in these complex cases.
By Sruthi Arepalli, MD
Getting Surgical Documentation Right
Coding Q&A
What vitreoretinal surgeons need to know about operative reports, medical necessity, and coding rules that impact reimbursement.
By Elizabeth Cifers, MBA, MSW, CHC, CPC
Clinical Trial Update July/August 2026
Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.
Supported Content
Comanagement Strategies in GA Care: Creating Seamless GA Referral Pathways That Work
Clear communication and continued involvement are key to successful disease management.
By Damon Dierker, OD, FAAO, Ankur M. Shah, MD, FASRS
A Closer Look at OLN324
In this month’s Retina Minute, Margaret A. Chang, MD, MS, reviews phase 2 JADE data evaluating the investigational bispecific therapy in neovascular AMD and diabetic macular edema.
By Michael A. Singer, MD, Margaret Chang, MD